An observational, prospective study to assess the use, effectiveness, and safety of voxelotor in patients with sickle cell disease (SCD) in a real-life setting (VoxEval) First published 05/06/2024 Last updated 24/02/2025 EU PAS number:EUPAS1000000186 Study Cancelled